We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > divest

News List

Bayer to divest Animal Health unit for $7.6bn pharmaceutical-technology
August 22, 2019
Bayer has signed a definitive agreement to sell its Animal Health unit to US-based Elanco Animal Health for a total of $7.6bn, in a bid to focus on its core life sciences businesses.
Dr Reddy’s announces closure of the transaction to divest Zembrace SymTouch and Tosymra to Upsher-Smith expresspharma
July 23, 2019
Dr Reddy’s Laboratories announced the closure of the transaction with Upsher-Smith Laboratories after the satisfactory completion of all customary closing conditions including the applicable waiting period under the Hart-Scott-Rodino Antitrust Improvement
BMS to divest Otezla for approval of $74bn merger with Celgene pharmaceutical-technology
June 26, 2019
Bristol-Myers Squibb (BMS) has offered to divest prescription medicine Otezla in order to receive approval for its $74bn merger with Celgene from the US Federal Trade Commission (FTC).
Takeda looking to divest emerging-market assets in wake of Shire acquisition firstwordpharma
January 22, 2019
According to people familiar with the matter, Takeda is mulling a sale of some emerging-market drugs as the company looks to find ways to cut debt after its $62-billion takeover of Shire earlier this month, Bloomberg reported Monday.